Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $1.61 billion. The enterprise value is $1.66 billion.

Market Cap	1.61B
Enterprise Value	1.66B

Important Dates

The last earnings date was Tuesday, March 31, 2026, after market close.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

Nanobiotix has 48.39 million shares outstanding. The number of shares has increased by 1.17% in one year.

Current Share Class	n/a
Shares Outstanding	48.39M
Shares Change (YoY)	+1.17%
Shares Change (QoQ)	+1.69%
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	7.85%
Float	31.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.05
Forward PS	13.55
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	43.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.09

Current Ratio	1.09
Quick Ratio	1.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.06%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-106.13%
Weighted Average Cost of Capital (WACC)	7.34%
Revenue Per Employee	$371,536
Profits Per Employee	-$273,137
Employee Count	103
Asset Turnover	0.48
Inventory Turnover	n/a

Taxes

In the past 12 months, Nanobiotix has paid $3,522 in taxes.

Income Tax	3,522
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +950.79% in the last 52 weeks. The beta is 0.55, so Nanobiotix's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+950.79%
50-Day Moving Average	31.31
200-Day Moving Average	20.59
Relative Strength Index (RSI)	54.04
Average Volume (20 Days)	73,598

Short Selling Information

The latest short interest is 11,234, so 0.02% of the outstanding shares have been sold short.

Short Interest	11,234
Short Previous Month	25,474
Short % of Shares Out	0.02%
Short % of Float	0.04%
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, Nanobiotix had revenue of $38.27 million and -$28.13 million in losses. Loss per share was -$0.59.

Revenue	38.27M
Gross Profit	38.27M
Operating Income	-12.78M
Pretax Income	-28.13M
Net Income	-28.13M
EBITDA	-12.32M
EBIT	-12.78M
Loss Per Share	-$0.59

Full Income Statement

Balance Sheet

The company has $61.93 million in cash and $111.92 million in debt, giving a net cash position of -$49.98 million or -$1.03 per share.

Cash & Cash Equivalents	61.93M
Total Debt	111.92M
Net Cash	-49.98M
Net Cash Per Share	-$1.03
Equity (Book Value)	-99.19M
Book Value Per Share	-2.05
Working Capital	6.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$39.24 million and capital expenditures -$631,678, giving a free cash flow of -$39.78 million.

Operating Cash Flow	-39.24M
Capital Expenditures	-631,678
Depreciation & Amortization	460,307
Net Borrowing	44.73M
Free Cash Flow	-39.78M
FCF Per Share	-$0.82

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -33.39% and -73.52%.

Gross Margin	100.00%
Operating Margin	-33.39%
Pretax Margin	-73.51%
Profit Margin	-73.52%
EBITDA Margin	-32.18%
EBIT Margin	-33.39%
FCF Margin	n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.17%
Shareholder Yield	-1.17%
Earnings Yield	-1.75%
FCF Yield	-2.47%

Analyst Forecast

The average price target for Nanobiotix is $36.00, which is 8.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.00
Price Target Difference	8.76%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	44.36%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of 1.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.11
Piotroski F-Score	1